In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against other firms that kicked off the trading week stronger. The stock market began ...

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving ...

In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little ...

It comes despite overwhelming opposition to the proposal which was one of three options which has been considered for the future Henry Cort Community College as well as meet the needs of the ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

The decision to “close” Fareham’s Henry Cort school is “cruel” and “unnecessary”, according to a local councillor who has slammed the move. Did you know with a Digital Subscription ...

Councillors have agreed to relocate a school despite fierce opposition. Henry Cort school in Fareham will now move to a location in North Whiteley from September 2027. The decision was made by ...

Henry Cort Community College in Fareham will move to a new site in North Whiteley. Hampshire County Council had previously approved the move, but following substantial opposition at two public ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Corcept Therapeutics (CORT) stock shot up over 100% yesterday as markets reacted to the company’s announcement of promising outcomes from its Phase 3 ROSELLA trial, which assessed the efficacy ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) just the other day announced that it had achieved the primary endpoint of its pivotal phase 3 ROSELLA study. This late-stage study tested the ...

or the purchase of call options or similar derivatives in CORT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other ...